INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
What is the latest Consolidated Net Profit of INDSWIFT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹421 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹-2.15 Cr |
| Mar2022 | ₹-3.15 Cr |
| Mar2021 | ₹-21 Cr |
How is Consolidated Net Profit of INDSWIFT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹421 Cr | 784.43 | |
| Mar2024 | ₹48 Cr | Positive | |
| Mar2023 | ₹-2.15 Cr | Negative | |
| Mar2022 | ₹-3.15 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Consolidated Net Profit of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,193.3 Cr | 2.5% | 59.2% | 297% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹112,212.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 2.5% |
59.2% |
297% |
| SENSEX | -1% |
-2.9% |
-4.9% |
You may also like the below Video Courses